Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
Toronto, Ontario--(Newsfile Corp. - March 31, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces it has secured a strategic commercial order for an initial
Technologies, Biotechnologies, Santé
2026-03-31 6:30 AM EDT | Therma Bright Inc.
Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial Results
Lake Oswego, Oregon--(Newsfile Corp. - March 30, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 highlights Revenue of $1.50 million compared to $1.68 million in the prior year period, a decrease of approximately 11.0%. This decrease was primarily due to the shift i
Produits ménagers / de consommation / cosmétiques, Santé
2026-03-30 8:00 AM EDT | Functional Brands Inc.
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
King of Prussia, Pennsylvania--(Newsfile Corp. - March 30, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that it has entered into a cGMP drug product manufacturing services agreement with a U.S. manufacturer for clinical supply for future clinical trials. The company will manufacture Phio's lead compo
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-03-30 7:00 AM EDT | Phio Pharmaceuticals Corp.
TempraMed Signs LOI for Distribution Agreement in Panama, Expanding Central American Exposure
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has signed a non-binding letter of intent ("LOI"), dated March 22, 2026, with TEM Consulting International S.A. ("TEM") a leading healthcare logistics and consultancy com
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-03-30 7:00 AM EDT | TempraMed Technologies Ltd.
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products, is pleased to announce the appointment of Dr. Raj S. Pruthi, MD, MHA, FACS, to its Board of Directors. Dr. Pruthi is an accomplished physician-scientist and executi
Biotechnologies, Pharmaceutique, Santé
2026-03-30 3:00 AM EDT | PreveCeutical Medical Inc.
The Future of Skin Aging May Be Found in The Kitchen: 2026 American Academy of Dermatology Annual Meeting to Highlight Latest Advancements in Skin, Hair, and Nails
Denver, Colorado--(Newsfile Corp. - March 27, 2026) - As interest grows in how lifestyle factors can influence people's appearance, dermatologists are taking a closer look at how diet may affect the internal and structural changes that contribute to the appearance of aged skin. Emerging research on the role of nutrition in skin aging is one of the timely and impactful topics that will be discussed at the 2026 American Academy of Dermatology (AAD) Annual Meeting, held March 27-31 in Denver, Co
Soins de santé et hôpitaux, Santé
2026-03-27 9:00 AM EDT | American Academy of Dermatology
Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant
Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces that it has entered into a second amending agreement (the "SIO Amendment") to its strategic investment and option agreement dated May 26, 2025, as previously amended (the "SIO Agreement"), with CWE European Holdings Inc. ("CWE"), operating as Hanf.com, one o
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-03-27 7:30 AM EDT | Neural Therapeutics Inc.
Glow Lifetech Reduces Over 41 Million Warrants and 5 Million Options, Strengthening Capital Structure; All $0.05 Warrants Now Expired
Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce a significant reduction in its outstanding share purchase warrants and stock options during the first quarter of 2026, marking an important milestone in the Company's ongoing efforts to further simplify its capital structure and reduce potential dilution. Significant Reduction in Warrant and Option Overhang
2026-03-27 7:30 AM EDT | Glow Lifetech Corp.
Tersis Secures Exclusive Agreement with Rhovia to Deploy Tucker Engineering's SynGenic V3 Waste-to-Energy Technology
Brooksville, Florida--(Newsfile Corp. - March 26, 2026) - Tersis (OTCID: TERS) today announced it has executed an exclusive agreement with Rhovia to commercialize and deploy Tucker Engineering's SynGenic V3 waste-to-energy platform, a next-generation technology engineered to convert complex waste streams into stable, continuous power infrastructure for high-demand commercial users. Under the agreement, Tersis has identified an initial development pipeline targeting 120-180 megawatts of
Agriculture, Énergie, Énergies de substitution, Santé
2026-03-26 11:25 AM EDT | Tersis Technologies Inc.
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory
Burlington, Ontario--(Newsfile Corp. - March 26, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology leader specializing in innovative oral thin film drug delivery, is pleased to provide shareholders with a strategic update highlighting its continued execution, operational resilience, and expanding global footprint. In an environment marked by global market volatility and geopolitical uncertainty, RDT is uniquely positioned
2026-03-26 9:09 AM EDT | Rapid Dose Therapeutics Corp.
Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition
Toronto, Ontario--(Newsfile Corp. - March 26, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its wholly owned subsidiary, First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, are pleased to announce an expansion of its dark fiber network with the addition of approximately 200 kilometres, increasing total network coverage to approximately 900 kilometres across Central Mexico. This milestone is expected to material
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-03-26 8:30 AM EDT | Akanda Corp
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 26, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a biotechnology company pioneering its proprietary Botanical Synthesis™ platform, today announced that its VINIA® brand has achieved the position of the #1 Resveratrol Polyphenol Nutraceutical Brand in the United States*. VINIA's leadership position is driven by its clinically demonstrate
Biotechnologies, Pharmaceutique, Santé
2026-03-26 7:30 AM EDT | BioHarvest Sciences Inc.
NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology
Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a Ready-to-Fill (RTF) COP/COC injection nozzle designed specifically for pharmaceutical needle-free applications. The nozzle, which is the subject of a newly filed patent application, represents a novel pharmaceutical packaging component that enables needle-free injection using established ase
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-03-25 5:15 PM EDT | NuGen Medical Devices Inc.
Cheelcare Announces Third Quarter 2026 Financial Results
Markham, Ontario--(Newsfile Corp. - March 25, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced its financial results for the third quarter ended January 31, 2026. All figures are in CAD unless otherwise noted. Operational Highlights (Three Months Ended January 31, 2026) Record quarterly revenue: The Company achieved its strongest quarterly
2026-03-25 7:30 AM EDT | Cheelcare Inc.
Apolo V Acquisition Corp. Announces Filing of Filing Statement in Connection with Qualifying Transaction
Toronto, Ontario--(Newsfile Corp. - March 24, 2026) - Apolo V Acquisition Corp. (TSXV: AFV.P) ("Apolo V") is pleased to announce that it has filed its filing statement (the "Filing Statement") dated March 24, 2026 on its SEDAR+ profile in connection with the proposed business combination among Apolo V, TelyRx, Inc. ("TelyRx"), TelyRx Finco Inc. ("Finco"), 1001474388 Ontario Inc., and Apolo V MergerCo Inc. (the "Proposed Transaction"). In conjunction with, an
Soins de santé et hôpitaux, Santé
2026-03-24 8:33 PM EDT | TelyRx
Numinus Wellness Provides Update Regarding Listing Status
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with an emphasis on safe, evidence-based psychedelic-assisted therapies, is providing an update regarding its listing status on the Toronto Stock Exchange ("TSX"). As previously disclosed in the Company's management information circular dated July 29,
2026-03-24 5:00 PM EDT | Numinus Wellness Inc.
Food and Drug Administration Adds AAMI Cybersecurity Guidance to Recognized Consensus Standards Database
Arlington, Virginia--(Newsfile Corp. - March 24, 2026) - The Food and Drug Administration (FDA) recently added the Association for the Advancement of Medical Instrumentation's primary guidance document on cybersecurity for artificial intelligence (AI) or machine learning (ML)-enabled medical devices to its database of recognized consensus standards. AAMI CR515:
2026-03-24 10:06 AM EDT | Association for the Advancement of Medical Instrumentation
UberDoc Health Technologies Corp. Announces Listing on the Frankfurt Stock Exchange
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) ("UberDoc" or the "Company"), an innovative healthcare platform empowering patients to connect with top physicians directly and without the wait, announced that its common shares have commenced trading on the Frankfurt Stock Exchange ("FSE") under the ticker symbol 4KL0. The Frankfurt listing follows the Comp
2026-03-24 8:30 AM EDT | UberDoc
Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building
Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual Zoom presentation happening tonight, Tuesday, March 24, 2026, at 6:00 PM EDT, with the Center for Autism and Related Disabilities (CARD) at the University of Central Florida (UCF). This high-impact session will deliver critical information directly to families, caregivers, and professionals
Soins de santé et hôpitaux, Santé
2026-03-24 8:00 AM EDT | Adia Nutrition Inc.
Promino Advances Rejuvenate Platform as Muscle Health Emerges as High-Growth Functional Beverage Category
Burlington, Ontario--(Newsfile Corp. - March 24, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company") today provided an update on its strategy to advance its Rejuvenate Muscle Health™ platform, as the muscle health category continues to gain momentum within the broader functional beverage market. A Platform Aligned with Major Health Trends Rejuvenate Muscle Health™ is powered by Promino's proprietary amino a
Aliments / boissons, Sports, Santé
2026-03-24 7:00 AM EDT | Promino Nutritional Sciences, Inc.